Kura Oncology KURA Institutional Ownership

Updated Oct 11, 2026

Kura Oncology, Inc. (NASDAQ:KURA) was reported as a holding by 218 institutional investors in 13F filings for the quarter ended June 30, 2026.

• Together they owned 97.57% of the outstanding stock in Q2 2026, up from 91.33% a quarter earlier.
• Total shares held in Kura Oncology rose 7.06% from Q1 2026, while the number of holders rose 21.79% from Q2 2025.
• Among the 218 holders of Kura Oncology, 119 added to their positions, 63 reduced their stakes and 36 left their positions unchanged.
• Institutional investors held 86.79Mn shares of Kura Oncology in total at the end of Q2 2026, up 5.72Mn from the prior quarter and up 6.98Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Kura Oncology was BlackRock, Inc. with 10.51Mn shares, or 11.81% of shares outstanding.
• The biggest increases in KURA positions during Q2 2026 came from AQR Capital Management LLC (+1Mn shares), BlackRock, Inc. (+871.7K shares), Goldman Sachs Group Inc (+831.7K shares), State Street Corp (+817.32K shares) and Alethea Capital Management, LLC (+638.57K shares).
• The largest position reductions in KURA for Q2 2026 were by Millennium Management LLC (-853.81K shares), Pale Fire Capital SE (-800.87K shares), Deep Track Capital, LP (-664.98K shares), Jane Street Group, LLC (-588.97K shares) and Qube Research & Technologies Ltd (-466.85K shares).
• According to Business Quant data, the leading holders of KURA for Q2 2026 were BlackRock, Inc. (10.51Mn shares), Montanova Capital, LLC (8.58Mn shares), BVF Inc (8.45Mn shares), State Street Corp (5.33Mn shares), Vanguard Capital Management LLC (3.92Mn shares), Armistice Capital, LLC (3.68Mn shares), AQR Capital Management LLC (3.13Mn shares), Goldman Sachs Group Inc (2.27Mn shares), Geode Capital Management, LLC (2.23Mn shares) and Alethea Capital Management, LLC (2.17Mn shares).